Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001080698 | SCV000262091 | benign | Long QT syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617359 | SCV000736353 | benign | Cardiovascular phenotype | 2016-11-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000058239 | SCV000885628 | likely benign | not provided | 2023-01-03 | criteria provided, single submitter | clinical testing | |
Cardiovascular Biomedical Research Unit, |
RCV000058239 | SCV000089759 | not provided | not provided | no assertion provided | literature only | This variant has been reported in the following publications (PMID:14661677;PMID:19841300). |